| scholarly article | Q13442814 |
| P50 | author | Mark Willcox | Q59432457 |
| Debarun Dutta | Q85313402 | ||
| P2093 | author name string | Muhammad Yasir | |
| P2860 | cites work | Pseudomonas aeruginosa attachment and biofilm development in dynamic environments. | Q52088150 |
| (p)ppGpp regulates type 1 fimbriation of Escherichia coli by modulating the expression of the site-specific recombinase FimB. | Q54462653 | ||
| Antimicrobial peptides | Q55982720 | ||
| Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescens WCS365 requires an ABC transporter and a large secreted protein | Q57340400 | ||
| Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system | Q59945098 | ||
| The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes | Q69075128 | ||
| Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens | Q73076636 | ||
| Introduction to biofilm | Q77965124 | ||
| Hydrophobic interactions in complexes of antimicrobial peptides with bacterial polysaccharides | Q80505630 | ||
| Biofilms: microbial life on surfaces | Q22305656 | ||
| Riddle of biofilm resistance | Q24550611 | ||
| Towards diagnostic guidelines for biofilm-associated infections | Q26862701 | ||
| Microbial biofilm formation: a need to act | Q27007396 | ||
| Antimicrobial peptides: their role as infection-selective tracers for molecular imaging | Q27014021 | ||
| Biofilm induced tolerance towards antimicrobial peptides | Q27301462 | ||
| Bacterial biofilms: a common cause of persistent infections | Q27861033 | ||
| Antimicrobial peptides of multicellular organisms | Q28131811 | ||
| Defensins: antimicrobial peptides of innate immunity | Q28204453 | ||
| (p)ppGpp: still magical? | Q28278758 | ||
| Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide | Q28284456 | ||
| Cationic antimicrobial peptides activate a two‐component regulatory system, PmrA‐PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa | Q28492717 | ||
| The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix | Q28492919 | ||
| Broad-spectrum anti-biofilm peptide that targets a cellular stress response | Q28539079 | ||
| The biofilm matrix | Q29547334 | ||
| Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? | Q29547675 | ||
| Bacterial biofilms: from the natural environment to infectious diseases | Q29547677 | ||
| Mechanisms of biofilm resistance to antimicrobial agents | Q29615293 | ||
| Biofilms as complex differentiated communities | Q29615299 | ||
| Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics | Q30502950 | ||
| Alginate production affects Pseudomonas aeruginosa biofilm development and architecture, but is not essential for biofilm formation | Q31074516 | ||
| Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora | Q33260522 | ||
| Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease | Q33723690 | ||
| PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance | Q39843622 | ||
| Production and characterization of the slime polysaccharide of Pseudomonas aeruginosa | Q40290468 | ||
| In situ and real time investigation of the evolution of a Pseudomonas fluorescens nascent biofilm in the presence of an antimicrobial peptide | Q40365825 | ||
| Peptide antibiotics and their role in innate immunity | Q40444944 | ||
| Synergistic Antipseudomonal Effects of Synthetic Peptide AMP38 and Carbapenems. | Q40540884 | ||
| Cationic antimicrobial peptides : issues for potential clinical use. | Q40570338 | ||
| Evaluation of the antibacterial and antibiofilm activities of novel CRAMP-vancomycin conjugates with diverse linkers. | Q40842456 | ||
| Bacterial alginate biosynthesis--recent progress and future prospects | Q40856886 | ||
| Mechanisms of biofilm inhibition and degradation by antimicrobial peptides | Q41242922 | ||
| Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides | Q41476984 | ||
| Synthetic Peptides to Target Stringent Response-Controlled Virulence in a Pseudomonas aeruginosa Murine Cutaneous Infection Model | Q41986754 | ||
| Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm | Q42110066 | ||
| The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding | Q43547658 | ||
| Characterization of the disulfide motif in BNBD-12, an antimicrobial beta-defensin peptide from bovine neutrophils | Q43982149 | ||
| A Linear 19-Mer Plant Defensin-Derived Peptide Acts Synergistically with Caspofungin against Candida albicans Biofilms | Q44194645 | ||
| Microcolonies, quorum sensing and cytotoxicity determine the survival of Pseudomonas aeruginosa biofilms exposed to protozoan grazing | Q44761421 | ||
| Helix induction in antimicrobial peptides by alginate in biofilms | Q44973236 | ||
| Nuclease activity gives an edge to host-defense peptide piscidin 3 over piscidin 1, rendering it more effective against persisters and biofilms. | Q46309064 | ||
| Antimicrobial Peptides: An Introduction | Q47375349 | ||
| Targeting microbial biofilms: current and prospective therapeutic strategies. | Q47637669 | ||
| Molecular genetics of bacterial attachment and biofouling | Q47896622 | ||
| PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance | Q48038471 | ||
| Combination Strategies to Enhance the Efficacy of Antimicrobial Peptides against Bacterial Biofilms | Q49631381 | ||
| Recognition of antimicrobial peptides by a bacterial sensor kinase. | Q50088065 | ||
| Synthetic antibiofilm peptides. | Q38685066 | ||
| Anti-Biofilm Activity of a Self-Aggregating Peptide against Streptococcus mutans | Q38732744 | ||
| Anti-biofilm peptides as a new weapon in antimicrobial warfare. | Q38869269 | ||
| ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. | Q39055760 | ||
| Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action | Q39210862 | ||
| Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria | Q39424118 | ||
| Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. | Q39450212 | ||
| Bacterial biofilms in nature and disease | Q39683472 | ||
| Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides | Q33789716 | ||
| An antimicrobial peptide that targets DNA repair intermediates in vitro inhibits Salmonella growth within murine macrophages | Q33826314 | ||
| The clinical impact of bacterial biofilms | Q33870211 | ||
| Effect of catalase on hydrogen peroxide penetration into Pseudomonas aeruginosa biofilms. | Q33986675 | ||
| Amphipathic, alpha-helical antimicrobial peptides | Q33994626 | ||
| A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms | Q34057449 | ||
| Biofilm formation: a clinically relevant microbiological process | Q34091923 | ||
| Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide | Q34165875 | ||
| Primate defensins | Q34348973 | ||
| The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing | Q34469399 | ||
| Molecular evolution of animal antimicrobial peptides: widespread moderate positive selection | Q34470823 | ||
| Cloning of the Streptococcus gordonii PK488 gene, encoding an adhesin which mediates coaggregation with Actinomyces naeslundii PK606 | Q34526701 | ||
| Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation | Q34527130 | ||
| Structural and functional studies on a proline-rich peptide isolated from swine saliva endowed with antifungal activity towards Cryptococcus neoformans | Q34527275 | ||
| Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. | Q34595498 | ||
| Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa | Q34597849 | ||
| Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes | Q34757004 | ||
| Medical biofilms | Q34764576 | ||
| Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis. | Q35124624 | ||
| Theoretical aspects of antibiotic diffusion into microbial biofilms | Q35128954 | ||
| D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections | Q35185982 | ||
| Testing the susceptibility of bacteria in biofilms to antibacterial agents | Q35279594 | ||
| The Staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides | Q35665343 | ||
| Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics | Q35746171 | ||
| Gram-positive three-component antimicrobial peptide-sensing system | Q35839651 | ||
| A re-evaluation of the role of host defence peptides in mammalian immunity. | Q36002887 | ||
| Survival strategies of infectious biofilms | Q36003660 | ||
| Molecular pathways underlying inhibitory effect of antimicrobial peptide Nal-P-113 on bacteria biofilms formation of Porphyromonas gingivalis W83 by DNA microarray | Q36284345 | ||
| Natural antimicrobial peptide complexes in the fighting of antibiotic resistant biofilms: Calliphora vicina medicinal maggots | Q36302767 | ||
| Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms | Q36326740 | ||
| Cationic host defense (antimicrobial) peptides | Q36335785 | ||
| New horizons for (p)ppGpp in bacterial and plant physiology. | Q36339121 | ||
| Biofilm in implant infections: its production and regulation. | Q36341333 | ||
| Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. | Q36449574 | ||
| The co-evolution of host cationic antimicrobial peptides and microbial resistance | Q36508686 | ||
| New trends in prosthesis infection in cardiovascular surgery | Q36559769 | ||
| Bacterial evasion of antimicrobial peptides by biofilm formation. | Q36566225 | ||
| The application of biofilm science to the study and control of chronic bacterial infections | Q36991151 | ||
| A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities. | Q37287708 | ||
| Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics | Q37317270 | ||
| Bacterial sensing of antimicrobial peptides | Q37421363 | ||
| Optimising Antibiotic Usage to Treat Bacterial Infections. | Q37444220 | ||
| Evolving concepts in biofilm infections | Q37449114 | ||
| Cross-kingdom interactions: Candida albicans and bacteria | Q37529923 | ||
| Antimicrobial Peptides: An Emerging Category of Therapeutic Agents | Q37532896 | ||
| Anionic antimicrobial peptides from eukaryotic organisms. | Q37596463 | ||
| Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections | Q37632964 | ||
| Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. | Q37643714 | ||
| Antibiotic resistance of bacterial biofilms | Q37690946 | ||
| Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity. | Q37699677 | ||
| Alpha-helical cationic antimicrobial peptides: relationships of structure and function | Q37825833 | ||
| Antimicrobial peptides: successes, challenges and unanswered questions | Q37827731 | ||
| Adaptive resistance to cationic compounds in Pseudomonas aeruginosa. | Q37835959 | ||
| Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials | Q38018423 | ||
| Biofilm-specific antibiotic resistance | Q38041189 | ||
| New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches. | Q38047034 | ||
| Biofilm infections, their resilience to therapy and innovative treatment strategies | Q38048367 | ||
| Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. | Q38123588 | ||
| Antimicrobial peptides: promising compounds against pathogenic microorganisms | Q38188627 | ||
| Eosinophil granule proteins: form and function | Q38209847 | ||
| Bacterial adherence and biofilm formation on medical implants: a review | Q38269190 | ||
| Human host defense peptide LL-37 prevents bacterial biofilm formation | Q38289682 | ||
| Mechanisms of adhesion by oral bacteria | Q38560901 | ||
| Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria | Q38622715 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biofilm | Q467410 |
| antimicrobial peptide | Q1201508 | ||
| P304 | page(s) | 2468 | |
| P577 | publication date | 2018-12-05 | |
| P1433 | published in | Materials | Q6786584 |
| P1476 | title | Action of Antimicrobial Peptides against Bacterial Biofilms | |
| P478 | volume | 11 |
| Q97526315 | Activated Polyhydroxyalkanoate Meshes Prevent Bacterial Adhesion and Biofilm Development in Regenerative Medicine Applications |
| Q92013941 | Anti-Biofilm Effects of Synthetic Antimicrobial Peptides Against Drug-Resistant Pseudomonas aeruginosa and Staphylococcus aureus Planktonic Cells and Biofilm |
| Q98178327 | Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy |
| Q97518347 | Biofilm and Pathogenesis-Related Proteins in the Foodborne P. fluorescens ITEM 17298 With Distinctive Phenotypes During Cold Storage |
| Q91801396 | Biofilms: Novel Strategies Based on Antimicrobial Peptides |
| Q90395695 | Differential Abilities of Mammalian Cathelicidins to Inhibit Bacterial Biofilm Formation and Promote Multifaceted Immune Functions of Neutrophils |
| Q92727312 | Flagella-dependent inhibition of biofilm formation by sub-inhibitory concentration of polymyxin B in Vibrio cholerae |
| Q92538088 | Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions |
| Q96685779 | Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells |
| Q92252011 | Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability |
| Q92990712 | Special Issue: Microbial Biofilms in Healthcare: Formation, Prevention and Treatment |
| Q93088225 | Turning a Collagenesis-Inducing Peptide Into a Potent Antibacterial and Antibiofilm Agent Against Multidrug-Resistant Gram-Negative Bacteria |
Search more.